AMP-Activated protein kinase phosphorylates cardiac troponin i and alters contractility of murine ventricular myocytes

AMP-Activated protein kinase phosphorylates cardiac troponin i and alters contractility of murine ventricular myocytes

Show other versions (2)

Rationale: AMP-activated protein kinase (AMPK) is an important regulator of energy balance and signaling in the heart. Mutations affecting the regulatory γ2 subunit have been shown to cause an essentially cardiac-restricted phenotype of hypertrophy and conduction disease, suggesting a specific role...

Full description

Bibliographic Details
Main Authors:	Oliveira, S, Zhang, Y, Solis, R, Isackson, H, Bellahcene, M, Yavari, A, Pinter, K, Davies, J, Ge, Y, Ashrafian, H, Walker, J, Carling, D, Watkins, H, Casadei, B, Redwood, C
Format:	Journal article
Language:	English
Published:	2012

Similar Items

AMP-Activated Protein Kinase Phosphorylates Cardiac Troponin I and Alters Contractility of Murine Ventricular Myocytes
by: Oliveira, S, et al.
Published: (2012)

AMP-activated protein kinase phosphorylates cardiac troponin I and alters contractility of murine ventricular myocytes.
by: Oliveira, S, et al.
Published: (2012)

Cardiac troponin I is a potential novel substrate for AMP-activated protein kinase
by: Oliveira, S, et al.
Published: (2007)

Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.
by: Ashley, E, et al.
Published: (2002)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function.
by: Robinson, P, et al.
Published: (2007)

Determination of AMP-activated protein kinase phosphorylation sites in recombinant protein expressed using the pET28a vector: a cautionary tale.
by: Renz, B, et al.
Published: (2009)

Force, Ca-Sensitivity and Contractile Efficiency in Human Myocardium Expressing a Truncated Cardiac Myosin Binding Protein-C
by: Griffiths, P, et al.
Published: (2010)

IS DEPRESSED MYOCYTE CONTRACTILITY AN EARLY EVENT IN THE NATURAL HISTORY OF HEART FAILURE?
by: Idigo, W, et al.
Published: (2010)

Regulation of myocyte contractility by endogenous NO: role of protein phosphatase 2A and protein kinase A-dependent signalling
by: Zhang, Y, et al.
Published: (2008)

Is depressed myocyte contractility an early event in the natural history of heart failure?
by: Idigo, W, et al.
Published: (2008)

Is depressed myocyte contractility an early event in the natural history of heart failure?
by: Idigo, W, et al.
Published: (2008)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
by: Burton, D, et al.
Published: (2002)

Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac Troponin-T on Calcium Buffering In Situ
by: Robinson, P, et al.
Published: (2010)

DEVELOPMENT AND CHARACTERISATION OF A NOVEL KNOCK-IN MODEL OF PRKAG2 CARDIOMYOPATHY
by: Yavari, A, et al.
Published: (2009)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
by: Redwood, C, et al.
Published: (2001)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
by: Preston, L, et al.
Published: (2007)

Mechanical and electrophysiological properties of murine hypertrophied left ventricular myocytes
by: Bryant, S, et al.
Published: (2001)

Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice.
by: Zhang, Y, et al.
Published: (2008)

Secondary phosphorylation in myocytes expressing FLAG-tagged and non-tagged phospho-mimetic cardiac troponin I
by: Sarah E. Lang, et al.
Published: (2017-12-01)

P387Knock-in mouse model of PRKAG2 cardiomyopathy (R299Q) exhibits altered Ca2+-dependent cardiac contractility and reduced protein kinase A activity.
by: Turtle, C, et al.
Published: (2014)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
by: Elliott, K, et al.
Published: (2000)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
by: Preston, L, et al.
Published: (2006)

Using fluorescence emission spectroscopy to asses the Ca2+ affinity of reconstituted troponin and thin filaments containing cardiomyopathy causing mutations of troponin and alpha-tropomyosin
by: Robinson, P, et al.
Published: (2007)

Cardiac myocyte intrinsic contractility and calcium handling deficits underlie heart organ dysfunction in murine cancer cachexia
by: Michelle L. Law, et al.
Published: (2021-12-01)

Enhancement of beta adrenergic responsiveness in myocytes lacking nitric oxide synthase 1
by: Ashley, E, et al.
Published: (2001)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
by: Elliott, K, et al.
Published: (2000)

Calcium Signaling and Contractility in Cardiac Myocyte of Wolframin Deficient Rats
by: Michal Cagalinec, et al.
Published: (2019-03-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Image Processing Techniques for Assessing Contractility in Isolated Adult Cardiac Myocytes
by: Carlos Bazan, et al.
Published: (2009-01-01)

Image Processing Techniques for Assessing Contractility in Isolated Neonatal Cardiac Myocytes
by: Carlos Bazan, et al.
Published: (2011-01-01)

Hypertrophic and dilated cardiomyopathycausing mutations of troponin and alpha-tropomyosin have opposite effects on thin filament calcium binding
by: Robinson, P, et al.
Published: (2007)

Neuronal nitric oxide synthase (NOS1) regulates beta-adrenergic contraction and calcium handling in isolated murine ventricular myocytes
by: Zhang, Y, et al.
Published: (2003)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
by: Bayliss, C, et al.
Published: (2013)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)
by: Grignani, R, et al.
Published: (2005)

Mutations in troponin T associated with Hypertrophic Cardiomyopathy increase Ca2+-sensitivity and suppress the modulation of Ca2+-sensitivity by troponin I phosphorylation
by: Messer, A, et al.
Published: (2016)

Functional effects of mutations in troponin T and tropomyosin which cause dilated cardiomyopathy
by: Robinson, P, et al.
Published: (2003)

A cardiac neuronal nitric oxide synthase isoform regulates contraction and calcium handling in murine ventricular myocytes
by: Sears, C, et al.
Published: (2002)

A cardiac neuronal nitric oxide synthase isoform regulates contraction and calcium handling in murine ventricular myocytes
by: Sears, C, et al.
Published: (2002)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)